Sulfasalazine inhibition of binding of N-Formyl-Methionyl-Leucyl-Phenylalanine (FMLP) to its receptor on human neutrophils
- 1 February 1984
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 33 (3), 407-412
- https://doi.org/10.1016/0006-2952(84)90233-8
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- The oligopeptide chemotactic factor receptor on human polymorphonuclear leukocyte membranes exists in two affinity statesBiochemical and Biophysical Research Communications, 1982
- Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.Journal of Clinical Investigation, 1982
- DUAL EFFECT OF SULPHASALAZINE ON COLONIC PROSTAGLANDIN SYNTHETASEThe Lancet, 1981
- Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.Journal of Clinical Investigation, 1980
- Mechanism of Action of Colchicine in Acute Urate Crystal-Induced ArthritisJournal of Clinical Investigation, 1979
- The Effect of Sulfasalazine and Its Active Components on Human Polymorphonuclear Leukocyte Function in Relation to Ulcerative ColitisActa Medica Scandinavica, 1979
- Urate crystal-induced chemotactic factor: isolation and partial characterization.Journal of Clinical Investigation, 1976
- The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.The Journal of Experimental Medicine, 1976
- A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin)Gut, 1973
- A Method for Assessing thein vitroChemotactic Response of Neutrophils Utilizing51FR-Labeled Hliman LeukocytesImmunological Communications, 1972